Skip to content
Bored Studies
RecruitingAccepts healthy volunteersEarly Phase 1

Vascular Effects of High-Salt After Preeclampsia

Anna Stanhewicz, PhD · NCT06749418

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–45 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Early Phase 1
Target enrollment
40
US sites recruiting
1
Study start
January 2, 2025
Record last updated
February 13, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy. Importantly, women who had preeclampsia have an exaggerated vascular responsiveness to hypertensive stimuli, such as high-salt intake, compared to women who had a healthy pregnancy. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during the preeclamptic pregnancy and persists postpartum, despite the remission of clinical symptoms. While the association between a history of preeclampsia and vascular dysfunction leading to elevated CVD risk is well known, the mechanisms underlying this dysfunction remains unclear.

The purpose of this study is to examine the role of vascular mineralocorticoid receptor, the terminal receptor in the angiotensin system that contributes to blood pressure regulation, in mediating exaggerated microvascular endothelial dysfunction before and after a high-salt stimulus. This will help us better understand the mechanisms of microvascular dysfunction these women, and how inhibition of these receptors may improve microvascular function.

In this study, we use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) we examine the blood vessels in a nickel-sized area of the skin.

Being studied: Eplerenone

Conditions: Preeclampsia; Preeclampsia Postpartum

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • women who had preeclampsia and women who did not have preeclampsia
  • 12 weeks to 5 years postpartum
  • 18-45 years old

Exclusion Criteria

  • history of hypertension or metabolic disease before pregnancy
  • history of gestational diabetes
  • history of gestational hypertension without preeclampsia
  • skin diseases
  • current tobacco use
  • current antihypertensive medication
  • statin or other cholesterol-lowering medication
  • currently pregnant
  • body mass index less than 18.5 kg/m2
  • allergy to materials used during the experiment.(e.g. latex),
  • known allergy to study drugs or salt-supplement

Recruiting US locations

  • University of Iowa

    Iowa City, IA 52242

    Site contact: Kelsey Schwartz, PhD · 319-467-1732 · kelsey-schwartz@uiowa.edu

Study contacts (from the official record)

  • Kelsey Schwartz, PhD · 319-467-1732 · kelsey-schwartz@uiowa.edu
All pregnancy studies in Iowa →
Vascular Effects of High-Salt After Preeclampsia (NCT06749418) | Bored Studies